Anticoagulation in atrial fibrillation.

  title={Anticoagulation in atrial fibrillation.},
  author={Benjamin A Steinberg and Jonathan P Piccini},
Atrial fibrillation increases the risk of stroke, which is a leading cause of death and disability worldwide. The use of oral anticoagulation in patients with atrial fibrillation at moderate or high risk of stroke, estimated by established criteria, improves outcomes. However, to ensure that the benefits exceed the risks of bleeding, appropriate patient selection is essential. Vitamin K antagonism has been the mainstay of treatment; however, newer drugs with novel mechanisms are also available… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 35 times. VIEW TWEETS


Publications citing this paper.
Showing 1-10 of 22 extracted citations


Publications referenced by this paper.
Showing 1-10 of 89 references

Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation : results from ROCKET AF

MW Sherwood, JD Douketis, +3 authors Y Lokhnygina
Circulation • 2014

Preventing stroke in patients with atrial fibrillation.

Dimensions of critical care nursing : DCCN • 2014

Similar Papers

Loading similar papers…